Last update 01 Nov 2024

Bemiparin sodium

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
Hibor
+ [3]
Target
Mechanism
AT III activators(Antithrombin-III activators)
Therapeutic Areas
Active Indication
Active Organization
Drug Highest PhaseApproved
First Approval Date
CN (06 Jan 2014),
Regulation-
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Venous Thromboembolism
CN
06 Jan 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
UlcerPhase 2-01 Jun 2001
Diabetic foot ulcerPhase 1
HR
01 Mar 2007
NeoplasmsPhase 1
PT
01 May 2005
NeoplasmsPhase 1
RO
01 May 2005
NeoplasmsPhase 1
RU
01 May 2005
NeoplasmsPhase 1
ES
01 May 2005
Venous ThromboembolismPhase 1
ES
01 May 2005
Venous ThromboembolismPhase 1
RU
01 May 2005
Venous ThromboembolismPhase 1
PT
01 May 2005
Venous ThromboembolismPhase 1
RO
01 May 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
100
(ledodsndtz) = jfuqeerfye cwfssgegfz (kqfydvckyp )
Positive
01 Jul 2017
(ledodsndtz) = ctmvwoyqwk cwfssgegfz (kqfydvckyp )
Not Applicable
-
7,020
slkkbhbjec(gtjmoklldh) = Adverse events in the enoxaparin group included wound dehiscence, haematoma, and separation przwcyujjf (tqnrbtmvdy )
-
28 Mar 2015
Phase 2
38
Standard chemoradiotherapy
(qstdnouggj) = cnjgcyhauo accyidzzun (bngiqyfmqf )
Positive
01 Jan 2013
Standard chemoradiotherapy + Bemiparin 3,500 IU daily
(qstdnouggj) = xhnrgurygk accyidzzun (bngiqyfmqf )
Phase 2
39
(xzpejqoset) = pyxexoriik pzuvjhpipb (fmviwqvtsg )
-
20 May 2012
(Standard CT-RT)
(xzpejqoset) = jknukddlxa pzuvjhpipb (fmviwqvtsg )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free